Clinical trial
The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone…
NCT00413244 · Icahn School of Medicine at Mount Sinai, Other · Completed
Key facts
| NCT number | NCT00413244 |
|---|---|
| Title | The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery |
| Official title | The Cardiac Benefit of Androgen Replacement in Hypogonadal Males With Coronary Artery Disease Following Successful Percutaneous Coronary Intervention (PCI). |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | AndroGel 5 Grams, Placebo |
| Enrollment | 51 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2014 |
| Completion | Nov 1, 2014 |
| First posted | Dec 19, 2006 |
| Last update posted | Jan 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: